Abstract

As compared with placebo, intravenous alteplase administered between 3 and 4.5 hours after the onset of symptoms significantly improved clinical outcomes in patients with acute ischemic stroke; alteplase was more frequently associated with symptomatic intracranial hemorrhage. (ClinicalTrials.gov number, NCT00153036.)

Keywords

MedicineThrombolysisStroke (engine)Ischemic strokeAcute strokeFibrinolytic agentTissue plasminogen activatorEmergency medicineAnesthesiaInternal medicineIschemiaMyocardial infarction

Affiliated Institutions

Related Publications

Publication Info

Year
2008
Type
article
Volume
359
Issue
13
Pages
1317-1329
Citations
6420
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

6420
OpenAlex

Cite This

Werner Hacke, Markku Kaste, Erich Bluhmki et al. (2008). Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke. New England Journal of Medicine , 359 (13) , 1317-1329. https://doi.org/10.1056/nejmoa0804656

Identifiers

DOI
10.1056/nejmoa0804656